Solvay to sell entire pharmaceutical business to Abbott, to invest in plastics

Solvay is to close a deal to sell its entire pharmaceutical business to Abbott for €5.2 bln in Q1-2010. The deal is subject to approval by the relevant competition authorities. Money raised by the sale will be invested in strategic projects in chemicals and plastics.
  More News  Post Your Comment
{{comment.Name}} made a post.




There are no comments to display. Be the first one to comment!


Name Required.


Email Id Required.

Email Id Not Valid.


Mobile Required.

Email ID and Mobile Number are kept private and will not be shown publicly.

Message Required.

Click to Change image  Refresh Captcha